These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22950641)

  • 1. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.
    Kirmizis D; Papagianni A; Belechri AM; Memmos D
    Nephrol Dial Transplant; 2011 Jul; 26(7):2296-301. PubMed ID: 21127134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Skoura L; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    J Atheroscler Thromb; 2010 Dec; 17(12):1256-65. PubMed ID: 20885069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of inflammation on anti-oxidative effects of vitamin E-coated membrane dialyzer in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Efstratiadis G; Memmos D
    Hemodial Int; 2014 Oct; 18(4):751-7. PubMed ID: 24641709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.
    Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB
    Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress.
    Takouli L; Hadjiyannakos D; Metaxaki P; Sideris V; Filiopoulos V; Anogiati A; Vlassopoulos D
    Ren Fail; 2010 Jan; 32(3):287-93. PubMed ID: 20370442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular effects of diet and statin in hypercholesterolemic patients.
    Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Choi YM; Ahn TH; Kim DS; Shin EK
    Int J Cardiol; 2004 Jun; 95(2-3):185-91. PubMed ID: 15193818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis.
    Yang SK; Xiao L; Xu B; Xu XX; Liu FY; Sun L
    Ren Fail; 2014 Jun; 36(5):722-31. PubMed ID: 24575826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on low-density lipoprotein cholesterol, interleukin-6, and high-sensitivity C-reactive protein in end-stage renal disease.
    Soliemani A; Nikoueinejad H; Tabatabaizade M; Mianehsaz E; Tamadon M
    Iran J Kidney Dis; 2011 Jan; 5(1):29-33. PubMed ID: 21189431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
    Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
    Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ann Nutr Metab; 2011; 58(3):197-202. PubMed ID: 21757893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
    Morena M; Gausson V; Mothu N; Bouchet JL; Chanas M; Grandvuillemin M; Robert A; Vela C; Canaud B; Cristol JP; Olmer M
    Blood Purif; 2008; 26(3):300-10. PubMed ID: 18451643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease.
    Stinghen AE; Gonçalves SM; Martines EG; Nakao LS; Riella MC; Aita CA; Pecoits-Filho R
    Nephron Clin Pract; 2009; 111(2):c117-26. PubMed ID: 19147993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.